Sleep problems are highly prevalent in children with Autism Spectrum Disorder (ASD), negatively impacting core symptoms, daytime functioning, and family well-being. While behavioral interventions are the first-line treatment, access is often limited. Digital and telehealth delivery models offer a promising approach to increase accessibility. This review systematically evaluates the effectiveness of these technology-based behavioral sleep interventions for youth with ASD. Following PRISMA guidelines, we systematically searched five databases for randomized controlled trials (RCTs) and non-randomized studies (NRCTs) of digital or telehealth behavioral sleep interventions for youth (2-18 years) with ASD. The primary outcome was child sleep. Two reviewers independently screened studies, extracted data, and assessed the risk of bias. We conducted random-effects meta-analyses and sensitivity analyses. 12 studies met inclusion criteria: 6 RCTs (N = 349) and 6 NRCTs (N = 57). Across RCTs, digital and telehealth interventions significantly improved parent-reported sleep problems compared with controls (pooled SMD = -0.57, 95 % CI -1.10 to -0.03; I2 = 62 %), reflecting a small-to-moderate benefit. Improvements were most evident for sleep initiation outcomes such as sleep-onset delay. In contrast, pooled NRCT results indicated large apparent gains (SMC = -1.03) but with wide confidence intervals and substantial heterogeneity, limiting interpretability. Evidence from randomized trials supports that digital and telehealth-delivered behavioral sleep interventions can yield small-to-moderate improvements in caregiver-reported sleep outcomes among autistic youth-particularly in reducing time to sleep onset. Non-randomized findings are encouraging but methodologically uncertain. Future research should prioritize adequately powered RCTs using objective sleep measures, standardized intervention frameworks, and longer follow-up to strengthen causal inference and inform scalable best-practice models.
Autism Spectrum Disorder (ASD) involves a multi-system interaction mechanism among genetics, immunity, and gut microbiota, yet its regulatory network remains undefined. This study conducted a meta-analysis on Genome-Wide Association Study data from four independent ASD cohorts to identify potential genetic loci. By integrating Polygenic Priority Score, brain region, and brain cell eQTL enrichment analyses, and combining summary-data-based Mendelian Randomisation (SMR) analyses of brain cis-eQTL and mQTL, bidirectional Mendelian Randomisation analyses of 473 gut microbiota, and SMR analysis of blood eQTL, SNPs such as rs2735307 and rs989134 with significant multi-dimensional associations were identified. These loci exert cross-tissue regulatory effects by participating in gut microbiota regulation, involving immune pathways such as T cell receptor signal activation and neutrophil extracellular trap formation, as well as cis-regulating neurodevelopmental genes ( HMGN1 and H3C9P ), or synergistically influencing epigenetic methylation modifications to regulate the expression of BRWD1 and ABT1 . The cross-scale evidence chain constructed in this study provides a theoretical foundation for precision medicine research in ASD, holding promise to advance the development of innovative therapeutic strategies.